Anthony Schramm Email

Director, Sales - North America East & Canada . Axion BioSystems

Current Roles

Employees:
206
Revenue:
$39.9M
About
Axion BioSystems is the leader in microelectrode array (MEA) data acquisition and analysis. With the Maestro MEA platform, functional activity assays on neural or cardiomyocyte cell networks are easily performed on the benchtop facilitating investigations in neurotoxicology, cardiac safety, in vitro disease modeling, and drug discovery. Scalability options from 12- to 96-wells and a new automation system, Maestro APEX, meets high throughput screening needs as well as assay development and follow-up studies - all with a single system. Looking to incorporate cutting-edge technology into your research High-throughput optogenetic stimulation (Lumos) is an available option to add to your Maestro, enabling simultaneous fine-tuned cellular control and real-time functional activity assessment. Tying this all together is AxIS, the integrated acquisition and analysis program that makes every MEA assay from experiment start to completed analysis simple and straightforward.
Axion BioSystems Address
1819 Peachtree Road NE
Atlanta, GA
United States
Axion BioSystems Email

Past Companies

Axion BioSystemsDirector, Sales - North America East & Canada
Axion BioSystemsMid Atlantic Senior Sales Manager (D.C., MD, NJ, PA, NY)
Axion BioSystemsAccount Manager - MidAtlantic (D.C., MD, NJ, PA, NY)

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.